Kaoru Matsui
Izumi-honcho, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Determination of Antimicrobial Resistance Megaplasmid-Like pESI Structures Contributing to the Spread of Salmonella Schwarzengrund in Japan.
Journal: Antibiotics (Basel, Switzerland)
Published: February 21, 2025
PD-1/PD-L1 checkpoint inhibitor-induced encephalitis in patients with lung adenocarcinoma: a report of three cases.
Journal: Oxford medical case reports
Published: July 17, 2024
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Journal: JTO clinical and research reports
Published: August 11, 2022
Molecular Characteristics and Antimicrobial Resistance of Salmonella enterica Serovar Schwarzengrund from Chicken Meat in Japan.
Journal: Antibiotics (Basel, Switzerland)
Published: October 15, 2021
Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: June 11, 2019
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Journal: The Lancet. Oncology
Published: December 07, 2013
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 27, 2011
Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.
Journal: Anticancer research
Published: October 04, 2011
Relapse of stage I small cell lung cancer ten or more years after the start of treatment.
Journal: Japanese journal of clinical oncology
Published: June 20, 2006
A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.
Journal: Japanese journal of clinical oncology
Published: April 23, 2005
Showing 1-10 of 10
Last Updated: 09/26/2026